EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation‐prone and less filterable proteoforms during virus filtration

Solomon Isu iD, Lilia Vinskus, Derek Silva, Kristina Cunningham, Thomas Elich, Patricia Greenhalgh, Adam Sokolnicki, Bala Raghunath

Biotechnology Progress · 2024

DOI: 10.1002/btpr.3451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Solomon Isu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Process Solutions, MilliporeSigma, Burlington, Massachusetts, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Filtration. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal antibodies (mAbs) are an essential class of biotherapeutics. A platform process is used for mAb development to ensure clinically safe and stable molecules. Regulatory authorities ensure that mAb production processes include sufficient viral clearance steps to achieve less than one virus particle per million doses of product. Virus filtration is used for size‐based removal of enveloped and nonenveloped viruses during downstream processing of mAbs. Process development in mAb purification relies on empirical approaches and often includes adsorptive prefiltration to mitigate virus filter fouling. Opportunities for molecular‐level prediction of mAb filterability are needed to plug the existing knowledge gap in downstream processing. A molecular‐level approach to understanding the factors influencing mAb filterability may reduce process development time, material loss, and processing costs due to oversized virus filters. In this work, pH step gradient fractionation was applied on polished bulk mAb feed to obtain concentrated pools of fractionated mAb variants. Biophysical properties and quality attributes of fractionated pools, including oligomeric state (size), isoelectric point profile, diffusion interaction parameters, and glycoform profile, were determined using bioanalytical methods. Filterability (loading and throughput) of fractionated pools were evaluated. Statistical methods were used to obtain correlations between quality attributes of mAb fractions and filterability on the Viresolve Pro virus filter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalFiltrationAnimalsVirusesHydrogen-Ion ConcentrationCHO CellsCricetulus

Stichwörter der Autor:innen

charge variantsglycoformsmonoclonal antibodiesproteoformsvirus filtration

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Process Solutions, MilliporeSigma, Burlington, Massachusetts, USA.

ORCID-Profile: Solomon Isu

Zitieren

APA

Isu, S., Vinskus, L., Silva, D., Cunningham, K., Elich, T., Greenhalgh, P., Sokolnicki, A., & Raghunath, B. (2024). Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation‐prone and less filterable proteoforms during virus filtration. Biotechnology Progress. https://doi.org/10.1002/btpr.3451

Vancouver

Isu S, Vinskus L, Silva D, Cunningham K, Elich T, Greenhalgh P, et al. Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation‐prone and less filterable proteoforms during virus filtration. Biotechnology Progress. 2024. doi:10.1002/btpr.3451

BibTeX
@article{Isu2024,
  author = {Isu, Solomon and Vinskus, Lilia and Silva, Derek and Cunningham, Kristina and Elich, Thomas and Greenhalgh, Patricia and Sokolnicki, Adam and Raghunath, Bala},
  title = {Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation‐prone and less filterable proteoforms during virus filtration},
  journal = {Biotechnology Progress},
  year = {2024},
  doi = {10.1002/btpr.3451}
}
Kostenlos starten →